But skepticism about AI’s impact on jobs, combined with perceptions about data centers’ disruptive impacts on communities, ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has been a scorcher for much of the Northern Hemisphere. June and July marked ...
The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
Machine learning is the ability of a machine to improve its performance based on previous results. Machine learning methods enable computers to learn without being explicitly programmed and have ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
What vector and graph databases actually do, why AI agents made both matter, which vendors offer UK hosting, and when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results